Loading…
Curanex Pharmaceuticals Inc is projected to decline to $0.1886 by 2027, a -11% move from its current price of $0.212. CURX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.2039 | $0.212 | $0.2204 | -0.01% |
| Aug 6 | $0.2006 | $0.2119 | $0.2239 | -0.02% |
| Aug 7 | $0.1981 | $0.2119 | $0.2267 | -0.04% |
| Aug 8 | $0.196 | $0.2119 | $0.2291 | -0.05% |
| Aug 9 | $0.1942 | $0.2119 | $0.2311 | -0.06% |
| Aug 10 | $0.1926 | $0.2118 | $0.233 | -0.07% |
| Aug 11 | $0.1911 | $0.2118 | $0.2348 | -0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.1911 | $0.2118 | $0.2348 | -0.09% |
| Week 2 | $0.1829 | $0.2116 | $0.2448 | -0.17% |
| Week 3 | $0.1769 | $0.2115 | $0.2528 | -0.26% |
| Week 4 | $0.1719 | $0.2113 | $0.2596 | -0.34% |
| Week 5 | $0.1677 | $0.2111 | $0.2658 | -0.43% |
| Week 6 | $0.1639 | $0.2109 | $0.2715 | -0.51% |
| Week 7 | $0.1605 | $0.2107 | $0.2768 | -0.60% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Curanex Pharmaceuticals Inc is a healthcare company focused on botanical drugs for inflammatory diseases. It develops Phyto-N for a range of therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc and changed its name to Curanex Pharmaceuticals Inc in November 2023.
Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
CURX is currently trading at $0.2052 with a market cap of $5.82M. It ranks 5236 by market capitalization. The price outlook is mixed over the horizon, with a year-by-year forecast showing periods of modest gains and some declines; for example, the 2030 average is $0.2166 with a 5.5% ROI, while by 2040 the average rises to $0.3089 with a 50.5% ROI and by 2050 the average is $0.60 with a 192.4% ROI.
A major floor 40.7% below — a decisive break under it would weaken the trend.
The nearest floor, 13.7% below — buyers have tended to step in here.
The nearest ceiling, 32.1% above — a clean break opens room to run.
A major ceiling 149.5% above — clearing it would confirm fresh momentum.
Key CURX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CURX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.1942 | Buy | $0.1973 | Buy |
| MA 10 | $0.1966 | Buy | $0.1997 | Buy |
| MA 20 | $0.2064 | Buy | $0.2133 | Sell |
| MA 50 | $0.2675 | Sell | $0.2601 | Sell |
| MA 100 | $0.3448 | Sell | $0.3655 | Sell |
| MA 200 | $0.3934 | Sell | $0.8135 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.68 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -9.77 | Neutral |
| Williams %R (14) | -37.14 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -4.65 | Sell |
| Bollinger %B (20,2) | 0.47 | Neutral |
| Stochastic %K (14) | 62.86 | Neutral |
| TRIX (15) | -1.42 | Sell |
| Awesome (5,34) | -0.04 | Sell |
| Ultimate (7,14,28) | 47.41 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 0.20 | Buy |
| ADX (14) | 34.58 | Sell |
| ATR (14) | 0.01 | Info |
The near-term technical picture is neutral. RSI14 is 40, indicating muted momentum. The stock trades with SMA50 at $0.2675 and SMA200 at $0.3934, suggesting the shorter-term trend sits below the longer-term average.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.183 | $0.212 | $0.2716 | 0% | Neutral | |
| $0.1376 | $0.1886 | $0.2793 | -11% | Neutral | |
| $0.117 | $0.1704 | $0.2692 | -20% | Bearish | |
| $0.1219 | $0.1871 | $0.3104 | -12% | Neutral | |
| $0.1388 | $0.2232 | $0.3855 | +5% | Neutral | |
| $0.1487 | $0.2499 | $0.4469 | +18% | Neutral | |
| $0.1386 | $0.2428 | $0.4478 | +15% | Neutral | |
| $0.1227 | $0.2238 | $0.4243 | +6% | Neutral | |
| $0.1265 | $0.24 | $0.4665 | +13% | Neutral | |
| $0.1137 | $0.2241 | $0.4457 | +6% | Neutral | |
| $0.1436 | $0.3192 | $0.6977 | +51% | Bullish | |
| $0.2791 | $0.6201 | $1.43 | +193% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.183 | $0.212 | $0.2555 | +0.00% |
| September 2026 | $0.1661 | $0.2019 | $0.2559 | -4.78% |
| October 2026 | $0.1702 | $0.2096 | $0.2711 | +3.85% |
| November 2026 | $0.1713 | $0.2134 | $0.2804 | +1.79% |
| December 2026 | $0.1618 | $0.2037 | $0.2716 | -4.54% |
Click any year to see its month-by-month CURX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CURX is projected to trade between $0.183 and $0.2716, averaging $0.212 — a potential gain of 0% from today's $0.212. A consolidation phase looks the most probable path here.
Curanex Pharmaceuticals Inc's 2027 outlook centres on $0.1886, within a $0.1376 to $0.2793 range. That is -11% versus the projected 2026 average. That marks a -11% change versus current levels. Price action looks broadly range-bound.
By 2028, CURX could reach as high as $0.2692, with a base case around $0.1704 and support toward $0.117 — roughly -20% from $0.212. Expect choppier, lower action through this leg of the cycle.
Expect CURX to range from $0.1219 to $0.3104 through 2029. The $0.1871 average target implies a -12% move from current prices. That is up +10% on the projected 2028 average. Price action looks broadly range-bound.
The CURX price prediction for 2030 points to an average of $0.2232 (low $0.1388, high $0.3855) — a potential gain of +5% on today's $0.212. A consolidation phase looks the most probable path here.
In 2031, CURX is projected to trade between $0.1487 and $0.4469, averaging $0.2499 — a potential gain of +18% from today's $0.212. That is up +12% on the projected 2030 average. Price action looks broadly range-bound.
Curanex Pharmaceuticals Inc's 2032 outlook centres on $0.2428, within a $0.1386 to $0.4478 range. That is -3% versus the projected 2031 average. That marks a +15% change versus current levels. A consolidation phase looks the most probable path here.
By 2033, CURX could reach as high as $0.4243, with a base case around $0.2238 and support toward $0.1227 — roughly +6% from $0.212. Price action looks broadly range-bound.
Expect CURX to range from $0.1265 to $0.4665 through 2034. The $0.24 average target implies a +13% move from current prices. That is up +7% on the projected 2033 average. A consolidation phase looks the most probable path here.
The CURX price prediction for 2035 points to an average of $0.2241 (low $0.1137, high $0.4457) — a potential gain of +6% on today's $0.212. Price action looks broadly range-bound.
In 2040, CURX is projected to trade between $0.1436 and $0.6977, averaging $0.3192 — a potential gain of +51% from today's $0.212. That is up +42% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Curanex Pharmaceuticals Inc's 2050 outlook centres on $0.6201, within a $0.2791 to $1.43 range. That is up +94% on the projected 2040 average. That marks a +193% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CURX today (≈ 4,716.981132 CURX) could be worth
$2,925.11
+$1,925.11 (+193%) by 2050 · US Dollar
Based on the average projected CURX price of $0.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CURXwould be worth at today's price.
$1,000 invested in CURX on Aug 26, 2025 (≈ 248.75622 CURX) would be worth
$52.74
-$947.26 (-94.7%) today · 0.05× · US Dollar
Based on a CURX entry price of $4.02 vs. today's $0.212.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.188 | $1,127.66 | +12.8% |
| 1 month ago | $0.274 | $773.72 | -22.6% |
| 3 months ago | $0.37 | $572.97 | -42.7% |
| 6 months ago | $0.332 | $638.55 | -36.1% |
| All time ago | $4.02 | $52.74 | -94.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CURX forecast.
Our base-case forecast reaches $0.42 around 2050.
Implied market cap at $0.42: $11.9M
The multi-year forecast shows a mixed path through 2026–2035, with several years in neutral territory and some upside later in the decade. For 2030, the avg is $0.2166 with a 5.5% ROI. By 2040, the avg rises to $0.3089 with a 50.5% ROI, and by 2050 the avg reaches $0.60 with a 192.4% ROI.
The forecast also shows bullish sentiment emerging in 2040 and 2050, while earlier years include fluctuations such as 2027 with -10.9% ROI and 2028 with -19.7% ROI. Overall volatility is high, with annualized volatility of 70%.
Tap a question to reveal the answer.
2030: min $0.1346, avg $0.2166, max $0.3741; ROI 5.5%; sentiment NEUTRAL.
The long-term outlook shows bullish potential by 2040 (avg $0.3089, ROI 50.5%) and by 2050 (avg $0.60, ROI 192.4%), but earlier years include neutral to bearish periods (e.g., 2027 ROI -10.9%, 2028 ROI -19.7%). The current price is $0.2052 with a market cap of $5.82M.
Yes—the max forecast for 2050 is $1.38, which would reach and exceed $1.
2040: min $0.139, avg $0.3089, max $0.6751; ROI 50.5%; sentiment BULLISH.
Curanex Pharmaceuticals Inc Community Discussion
0Share your Curanex Pharmaceuticals Inc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.